\
&
Contact us
\
&
Contact us
Published on | 2 years ago
ProgrammesIn case you were not able to register for onsite attendance in Mons at the Marie Skłodowska-Curie Actions (MSCA) Presidency Conference 2024 on the multiple pathways of researchers' careers rest assured that you can participate anyway. Did you know that it is possible to watch the conference from anywhere in the world on your screen?
The whole conference except the parallel sessions on 18 April (workshop 1, 2 & 3 and roundtable 2) are web streamed live. Check out the biographies of all speakers at the conference and the 15 MSCA Falling Walls Lab contestants. The full agenda and web stream of the conference are available on the MSCA Presidency Conference website here.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Climate, Energy, Mobility Agro-Food, Environment
Abstract submission and registration are open for the first European Partnership on Animal Health and Welfare Scientific Conference. The event is set to take place in Milan, Italy, from 19 to 22 January 2027 and invites contributions from both EUP AH&W members and non-members. Abstracts are due by 31 August 2026. The conference is designed to... read more
Digital, Industry & Space Agro-Food, Environment
The 2nd EO 4 Soil Symposium is organised by the European Space Agency (ESA) and focusses on three thematic areas: policy and user uptake scientific and technical progress applications and use cases Topics include soil monitoring methods, soil organic carbon mapping, uncertainty assessment, data harmonisation, soil carbon certific... read more
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
